IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,446,653 | +1.8% | 539,807 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $5,351,000 | +2.5% | 539,807 | +1.4% | 0.01% | +9.1% |
| Q2 2022 | $5,220,000 | 0.0% | 532,185 | 0.0% | 0.01% | +10.0% |
| Q1 2022 | $5,220,000 | +1.0% | 532,185 | +0.2% | 0.01% | 0.0% |
| Q4 2021 | $5,166,000 | +18.5% | 531,385 | +18.1% | 0.01% | -44.4% |
| Q3 2021 | $4,360,000 | +0.2% | 449,994 | 0.0% | 0.02% | -10.0% |
| Q2 2021 | $4,351,000 | – | 449,994 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |